Avalere | The intersection of business strategy and public policy
Home About Avalere Health Research Portfolio News Services Events Staff Contact Us

 

About half of the use of anticancer chemotherapy drugs is for “off-label” indications – uses not listed on the FDA-approved label.  Public and private payers typically cover off-label indications for anticancer drugs if they are listed in the compendia or supported in peer-reviewed medical literature. Coverage and payment for off-label uses of anticancer drugs has contributed to the widespread availability of these critical therapies.

Both public and private payers are examining their choices of compendia for determining medically-accepted uses of anticancer drugs.  CMS recently established an annual compendia review process.  CMS will accept requests for changes to its approved list of compendia, and will publish final decisions by July 15 after collecting public comments.  CMS’ decisions are poised to have an immediate impact on Medicare coverage. Concurrently, private payers are endorsing specific compendia for use in making coverage decisions for chemotherapy drugs. 

Join Avalere Health for a 90-minute interactive audio conference that will highlight:

  • The evolving landscape of compendia and their use in coverage decision-making by Medicare and private payers
  • CMS’ current efforts to revise the official list of approved compendia
  • Trends in the use of compendia by commercial payers
  • Variations in use of compendia at the regional and local levels by medical directors
  • Impact of state mandates on the use of compendia
» Purchase CD-ROM

  • Louis B. Jacques, MD, Director, Division of Items and Devices, CMS
  • Laurence Clark, MD, FACP, Senior Health Advisor at MARC Associates and former Mid-Atlantic Medical Director for Trailblazer Medicare
  • Derek van Amerongen, MD, MS, Chief Medical Officer, Humana Health Plan of Ohio
  • Gary M. Owens, MD, President of Gary Owens Associates and former Vice President for Medical Management and Policy at Independence Blue Cross
  • David Silk, Manager, Avalere Health

Registration Prices :
Avalere Client
$300
Commercial
$375
Government
$50
Hill Staff
Complimentary
Nonprofit
Special rates apply*

*For information, please call Tom Moreno at 202.207.3471 or email tmoreno@avalerehealth.net.

Cancellation Policy: To receive a refund, notice is required at least seven business days prior to the audio conference. With proper notice, fees are refunded minus a $40 service fee. No refunds are given for cancellations received with less than seven days notice. Avalere Health reserves the right to cancel or reschedule an audio conference due to unforeseen circumstances.